Halabi S - Search Results

1

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A. Spillman MA, et al. Among authors: halabi s. Gynecol Oncol. 2005 May;97(2):543-9. doi: 10.1016/j.ygyno.2005.01.025. Gynecol Oncol. 2005. PMID: 15863158

2

Prognostic factors in early-onset epithelial ovarian cancer: a population-based study.

Schildkraut JM, Halabi S, Bastos E, Marchbanks PA, McDonald JA, Berchuck A. Schildkraut JM, et al. Among authors: halabi s. Obstet Gynecol. 2000 Jan;95(1):119-27. doi: 10.1016/s0029-7844(99)00535-9. Obstet Gynecol. 2000. PMID: 10636514

3

Age at natural menopause and the risk of epithelial ovarian cancer.

Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Schildkraut JM, et al. Among authors: halabi s. Obstet Gynecol. 2001 Jul;98(1):85-90. doi: 10.1016/s0029-7844(01)01388-6. Obstet Gynecol. 2001. PMID: 11430962 Review.

4

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Moorman PG, et al. Among authors: halabi s. Cancer Causes Control. 2002 Nov;13(9):807-11. doi: 10.1023/a:1020678100977. Cancer Causes Control. 2002. PMID: 12462545

5

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Among authors: halabi s. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

6

Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G. Berchuck A, et al. Among authors: halabi s. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2141-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598772

7

Antidepressant medication use [corrected] and risk of ovarian cancer.

Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Moorman PG, et al. Among authors: halabi s. Obstet Gynecol. 2005 Apr;105(4):725-30. doi: 10.1097/01.AOG.0000157113.98061.eb. Obstet Gynecol. 2005. PMID: 15802397

8

Menopausal hormones and risk of ovarian cancer.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A. Moorman PG, et al. Among authors: halabi s. Am J Obstet Gynecol. 2005 Jul;193(1):76-82. doi: 10.1016/j.ajog.2004.11.013. Am J Obstet Gynecol. 2005. PMID: 16021062

9

Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women.

Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM. Hoyo C, et al. Among authors: halabi s. Cancer Causes Control. 2005 Oct;16(8):955-63. doi: 10.1007/s10552-005-3205-y. Cancer Causes Control. 2005. PMID: 16132804

10

Analgesic drug use and risk of ovarian cancer.

Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A. Schildkraut JM, et al. Among authors: halabi s. Epidemiology. 2006 Jan;17(1):104-7. doi: 10.1097/01.ede.0000190538.55645.f8. Epidemiology. 2006. PMID: 16357602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

534 results

Search Page